JPRN-UMIN000035580已完成未知
Prospective pharmacokinetic study of continuous-infusional 5-FU - Pharmacokinetic study of 5-F
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Uncontrolled diarrhea (Grade =>2)
研究者
相似试验
尚未招募
Unknown
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patientsTuberculosisACTRN12623001088639Western Sydney Local Health District30
已完成
不适用
Second-line antiretrovirals - Food interaction studyHIV/AIDSPACTR2010030001953121Infectious Diseases Institute15
招募中
不适用
Pharmacological study of chronomodulated capecitabine therapycancer, capecitabine, phase I, chronotherapy, biomarker, pharmacology, kanker, chronotherapie, fase INL-OMON24089etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital42
招募中
不适用
Phase I pharmacological study of continuous and intermittent chronomodulated capecitabine therapymalignancies10027655cancerNL-OMON40756Antoni van Leeuwenhoek Ziekenhuis42
进行中（未招募）
不适用
An Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza during Lactation. - Observational PK studyactating women who present with clinical symptoms indicative of influenza will be recruited to receive immediate treatment with oseltamivir at a standard dose of 75 mg twice daily. These subjects will have a 12 hour pharmacokinetic plasma, urine and breast milk study undertaken after the steady state in oseltamivir concentrations (both active and inactive metabolites will be measured) is reached in blood, i.e. after three days after treatment.MedDRA version: 12.1Level: LLTClassification code 10022000Term: InfluenzaEUCTR2010-019372-72-HUPharmahungary Group